Amneal Pharmaceuticals (AMRX) Other Accumulated Expenses (2018 - 2019)

Amneal Pharmaceuticals' Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $35.9 million for Q4 2019.

• In Q4 2019, Other Accumulated Expenses fell 0.82% year-over-year to $35.9 million; the TTM figure through Dec 2019 stood at $35.9 million (down 0.82% YoY), while the FY2019 annual figure was $35.9 million, down 0.82% from the prior year.
• Other Accumulated Expenses for Q4 2019 stood at $35.9 million, down from $36.2 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $36.2 million in Q4 2018, with the low at $35.9 million in Q4 2019.